 BRIDGEWATER, N.J., May 16, 2022 GLOBE NEWSWIRE -- RVL Pharmaceuticals plc Nasdaq: RVLP RVL or the Company, a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive Officer, will present at two upcoming conferences as follows: 